Method for prediction of cold airway hyperreactivity correction efficiency in bronchial asthma patients with application of extra-fine aerosol for inhalations of beclomethasone dipropionate/formoterol fumarate
RU2705624C1
Method for assessing the rehabilitation potential in the elderly patients with stage iii discirculatory encephalopathy
RU2707095C1
Method for diagnosing the severity of chronic placental insufficiency in women seropositive for cytomegalovirus
RU2710588C1
Method for prediction of anemia in pregnant women with cytomegalovirus infection
RU2707184C1
Method for prediction of lethal outcome in hypertensive hydrocephalus syndrome in full-term newborns with congenital cytomegalovirus infection
RU2693054C1
Method for prediction of hemic hypoxia in cytomegalovirus infection in pregnant women
RU2685554C1
Method for assessing embryo implantation disorder in pregnancy complicated by cytomegalovirus infection by determining cyclooxygenase-2 in chorionic villous homogenate
RU2674159C1
Method for assessing the threat to the formation of fetal organs with an increase in the placenta content of 11-deoxycortisol in the third trimester of gestation with exacerbation of cytomegalovirus infection
RU2691935C2
Method for prediction of placental insufficiency in second half of pregnancy in cmv-seropositive women with threat of early miscarriage
RU2687971C1
Method for assessing damaging effect of cytomegaloviral infection on myristic acid content in umbilical cord blood of newborns from mothers suffered cytomegalovirus infection reactivation in third trimester
RU2664446C1
Method for predicting the threat of early terms miscarriage in case of cytomegalovirus infection by determining the placental growth factor in blood
RU2655543C1
Method of medical rehabilitation of patients with partially controlled mild bronchial asthma
RU2644831C1
Method for predicting the tightening of acute nazofaringetic in women with reactivation of chronic mixed-herpesvirus infection in the second trimester of pregnancy
RU2648472C1
Method for prediction of adverse perinatal outcomes with fetal growth retardation syndrome in women with reactivation of chronic cytomegalovirus infection in second trimester of pregnancy complicated by retroplacentary hematoma
RU2657429C2
Method for predicting the delay in formation of placenta and development of embryo with exacerbation of cytomegalovirus infection, suppressing activity of the vascular endothelial factor and embryo development
RU2634252C1
Method for diagnostics of pregnancy interruption on week 7-9 of gestation due to suppressed activity of membrane receptors to progesterone with cytomegalovirus infection exacerbation
RU2624519C1
Method for determination of human embryo implantation into uterine mucous membrane, depending on content of active receptors to estrogenes in chorion at cytomegalovirus infection exacerbation at first trimester of gestation
RU2620565C1
Method for determination of miscarriage threat formation during the first trimester of gestation in case of cytomegalovirus infection in exacerbation period of hypoxia induced factor
RU2648031C2
Method for premature birth prediction in second trimester of gestation associated with previous influenza a(h3n2) in first trimester of pregnancy complicated by retrochorial hematoma
RU2659700C2
Method for predicting the effectiveness of treatment with immunovenin in disimmunoglobulinemia due to the reactivation of chronic herpesvirus infection in women in the second trimester of pregnancy
